Latest Articles

  • The impact of anti-TNF therapy on the nonspecialist
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 71-72; DOI: https://doi.org/10.3949/ccjm.81b.02014

    These drugs are being used in a growing number of diseases. We all need to increase our familiarity with their unique risks.

  • In Reply: Canagliflozin (November 2013)
    Mary Vouyiouklis, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 90; DOI: https://doi.org/10.3949/ccjm.81c.02005
  • Reviewers 2013
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 102;
  • Managing risks of TNF inhibitors: An update for the internist
    Jennifer Hadam, MD, Elie Aoun, MD, MS, Kofi Clarke, MD and Mary Chester Wasko, MD, MSc
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 115-127; DOI: https://doi.org/10.3949/ccjm.81a.12121

    Tumor necrosis factor inhibitors pose infrequent but serious risks, including infection and malignancy.

  • Canagliflozin (November 2013)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 88-90; DOI: https://doi.org/10.3949/ccjm.81c.02004
  • In Reply: Stiff, numb hands (June 2013)
    Khaldoon Shaheen, MD and Srinivas Merugu, MD, MMM
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87; DOI: https://doi.org/10.3949/ccjm.81c.02002

    Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

  • Stiff, numb hands (June 2013)
    Morton H. Field, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87; DOI: https://doi.org/10.3949/ccjm.81c.02001

    Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

  • Canagliflozin (November 2013)
    René Rodríguez-Gutiérrez, MD and Gloria Gonzalez-Saldivar, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87-88; DOI: https://doi.org/10.3949/ccjm.81c.02003

    Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

  • Wide QRS complex rhythm with pulseless electrical activity
    Laszlo Littmann, MD, PhD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 81-82; DOI: https://doi.org/10.3949/ccjm.81a.13079

    Although this presentation is grave, several of its possible causes can be treated, allowing the patient to recover.

  • Anticoagulation and antiplatelet therapy in acute coronary syndromes
    Anticoagulation and antiplatelet therapy in acute coronary syndromes
    Dhssraj Singh, MD, Kamal Gupta, MD and James L. Vacek, MD, MSc
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 103-114; DOI: https://doi.org/10.3949/ccjm.81a.13016

    Antiplatelet and anticoagulant drugs prevent ischemic events but can cause bleeding. Here is how to optimize the benefit.

Pages